Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)

NCT01831934 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

MELAS Syndrome

Interventions

BIOLOGICAL: Fluzone®

Sponsor

Stanford University

Collaborators

[object Object]